The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Closed System for Drug Transfer-Global Market Insights and Sales Trends 2024
Synopsis
Closed system for drug transfer is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system.
The global Closed System for Drug Transfer market size is expected to reach US$ 1906.2 million by 2029, growing at a CAGR of 18.7% from 2023 to 2029. The market is mainly driven by the significant applications of Closed System for Drug Transfer in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Closed System for Drug Transfer market. for Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the for Syringe segment is estimated at % CAGR for the next seven-year period.
North America is the largest market, with a share about 75%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Closed System for Drug Transfer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Closed System for Drug Transfer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Closed System for Drug Transfer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Closed System for Drug Transfer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Closed System for Drug Transfer covered in this report include BD Medical, Inc, Equashield, ICU Medical, Simplivia Healthcare Ltd., Corvida Medical and B. Braun, etc.
The global Closed System for Drug Transfer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD Medical, Inc
Equashield
ICU Medical
Simplivia Healthcare Ltd.
Corvida Medical
B. Braun
Global Closed System for Drug Transfer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Closed System for Drug Transfer market, Segment by Type:
for Vial
for Syringe
for Bag/Line
Global Closed System for Drug Transfer market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Closed System for Drug Transfer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Closed System for Drug Transfer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Closed system for drug transfer is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system.
The global Closed System for Drug Transfer market size is expected to reach US$ 1906.2 million by 2029, growing at a CAGR of 18.7% from 2023 to 2029. The market is mainly driven by the significant applications of Closed System for Drug Transfer in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Closed System for Drug Transfer market. for Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the for Syringe segment is estimated at % CAGR for the next seven-year period.
North America is the largest market, with a share about 75%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Closed System for Drug Transfer, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Closed System for Drug Transfer market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Closed System for Drug Transfer market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Closed System for Drug Transfer sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Closed System for Drug Transfer covered in this report include BD Medical, Inc, Equashield, ICU Medical, Simplivia Healthcare Ltd., Corvida Medical and B. Braun, etc.
The global Closed System for Drug Transfer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD Medical, Inc
Equashield
ICU Medical
Simplivia Healthcare Ltd.
Corvida Medical
B. Braun
Global Closed System for Drug Transfer market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Closed System for Drug Transfer market, Segment by Type:
for Vial
for Syringe
for Bag/Line
Global Closed System for Drug Transfer market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Closed System for Drug Transfer manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Closed System for Drug Transfer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Closed System for Drug Transfer Market Overview
1.1 Closed System for Drug Transfer Product Overview
1.2 Closed System for Drug Transfer Market Segment by Type
1.2.1 for Vial
1.2.2 for Syringe
1.2.3 for Bag/Line
1.3 Global Closed System for Drug Transfer Market Size by Type
1.3.1 Global Closed System for Drug Transfer Market Size Overview by Type (2018-2029)
1.3.2 Global Closed System for Drug Transfer Historic Market Size Review by Type (2018-2023)
1.3.3 Global Closed System for Drug Transfer Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Closed System for Drug Transfer Sales Breakdown by Type (2018-2023)
1.4.2 Europe Closed System for Drug Transfer Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Closed System for Drug Transfer Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Closed System for Drug Transfer Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Closed System for Drug Transfer Sales Breakdown by Type (2018-2023)
2 Global Closed System for Drug Transfer Market Competition by Company
2.1 Global Top Players by Closed System for Drug Transfer Sales (2018-2023)
2.2 Global Top Players by Closed System for Drug Transfer Revenue (2018-2023)
2.3 Global Top Players by Closed System for Drug Transfer Price (2018-2023)
2.4 Global Top Manufacturers Closed System for Drug Transfer Manufacturing Base Distribution, Sales Area, Product Type
2.5 Closed System for Drug Transfer Market Competitive Situation and Trends
2.5.1 Closed System for Drug Transfer Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Closed System for Drug Transfer Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Closed System for Drug Transfer as of 2022)
2.7 Date of Key Manufacturers Enter into Closed System for Drug Transfer Market
2.8 Key Manufacturers Closed System for Drug Transfer Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Closed System for Drug Transfer Status and Outlook by Region
3.1 Global Closed System for Drug Transfer Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Closed System for Drug Transfer Historic Market Size by Region
3.2.1 Global Closed System for Drug Transfer Sales in Volume by Region (2018-2023)
3.2.2 Global Closed System for Drug Transfer Sales in Value by Region (2018-2023)
3.2.3 Global Closed System for Drug Transfer Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Closed System for Drug Transfer Forecasted Market Size by Region
3.3.1 Global Closed System for Drug Transfer Sales in Volume by Region (2024-2029)
3.3.2 Global Closed System for Drug Transfer Sales in Value by Region (2024-2029)
3.3.3 Global Closed System for Drug Transfer Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Closed System for Drug Transfer by Application
4.1 Closed System for Drug Transfer Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Closed System for Drug Transfer Market Size by Application
4.2.1 Global Closed System for Drug Transfer Market Size Overview by Application (2018-2029)
4.2.2 Global Closed System for Drug Transfer Historic Market Size Review by Application (2018-2023)
4.2.3 Global Closed System for Drug Transfer Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Closed System for Drug Transfer Sales Breakdown by Application (2018-2023)
4.3.2 Europe Closed System for Drug Transfer Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Closed System for Drug Transfer Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Closed System for Drug Transfer Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Closed System for Drug Transfer Sales Breakdown by Application (2018-2023)
5 North America Closed System for Drug Transfer by Country
5.1 North America Closed System for Drug Transfer Historic Market Size by Country
5.1.1 North America Closed System for Drug Transfer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Closed System for Drug Transfer Sales in Volume by Country (2018-2023)
5.1.3 North America Closed System for Drug Transfer Sales in Value by Country (2018-2023)
5.2 North America Closed System for Drug Transfer Forecasted Market Size by Country
5.2.1 North America Closed System for Drug Transfer Sales in Volume by Country (2024-2029)
5.2.2 North America Closed System for Drug Transfer Sales in Value by Country (2024-2029)
6 Europe Closed System for Drug Transfer by Country
6.1 Europe Closed System for Drug Transfer Historic Market Size by Country
6.1.1 Europe Closed System for Drug Transfer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Closed System for Drug Transfer Sales in Volume by Country (2018-2023)
6.1.3 Europe Closed System for Drug Transfer Sales in Value by Country (2018-2023)
6.2 Europe Closed System for Drug Transfer Forecasted Market Size by Country
6.2.1 Europe Closed System for Drug Transfer Sales in Volume by Country (2024-2029)
6.2.2 Europe Closed System for Drug Transfer Sales in Value by Country (2024-2029)
7 Asia-Pacific Closed System for Drug Transfer by Region
7.1 Asia-Pacific Closed System for Drug Transfer Historic Market Size by Region
7.1.1 Asia-Pacific Closed System for Drug Transfer Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Closed System for Drug Transfer Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Closed System for Drug Transfer Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Closed System for Drug Transfer Forecasted Market Size by Region
7.2.1 Asia-Pacific Closed System for Drug Transfer Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Closed System for Drug Transfer Sales in Value by Region (2024-2029)
8 Latin America Closed System for Drug Transfer by Country
8.1 Latin America Closed System for Drug Transfer Historic Market Size by Country
8.1.1 Latin America Closed System for Drug Transfer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Closed System for Drug Transfer Sales in Volume by Country (2018-2023)
8.1.3 Latin America Closed System for Drug Transfer Sales in Value by Country (2018-2023)
8.2 Latin America Closed System for Drug Transfer Forecasted Market Size by Country
8.2.1 Latin America Closed System for Drug Transfer Sales in Volume by Country (2024-2029)
8.2.2 Latin America Closed System for Drug Transfer Sales in Value by Country (2024-2029)
9 Middle East and Africa Closed System for Drug Transfer by Country
9.1 Middle East and Africa Closed System for Drug Transfer Historic Market Size by Country
9.1.1 Middle East and Africa Closed System for Drug Transfer Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Closed System for Drug Transfer Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Closed System for Drug Transfer Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Closed System for Drug Transfer Forecasted Market Size by Country
9.2.1 Middle East and Africa Closed System for Drug Transfer Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Closed System for Drug Transfer Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BD Medical, Inc
10.1.1 BD Medical, Inc Company Information
10.1.2 BD Medical, Inc Introduction and Business Overview
10.1.3 BD Medical, Inc Closed System for Drug Transfer Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BD Medical, Inc Closed System for Drug Transfer Products Offered
10.1.5 BD Medical, Inc Recent Development
10.2 Equashield
10.2.1 Equashield Company Information
10.2.2 Equashield Introduction and Business Overview
10.2.3 Equashield Closed System for Drug Transfer Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Equashield Closed System for Drug Transfer Products Offered
10.2.5 Equashield Recent Development
10.3 ICU Medical
10.3.1 ICU Medical Company Information
10.3.2 ICU Medical Introduction and Business Overview
10.3.3 ICU Medical Closed System for Drug Transfer Sales, Revenue and Gross Margin (2018-2023)
10.3.4 ICU Medical Closed System for Drug Transfer Products Offered
10.3.5 ICU Medical Recent Development
10.4 Simplivia Healthcare Ltd.
10.4.1 Simplivia Healthcare Ltd. Company Information
10.4.2 Simplivia Healthcare Ltd. Introduction and Business Overview
10.4.3 Simplivia Healthcare Ltd. Closed System for Drug Transfer Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Simplivia Healthcare Ltd. Closed System for Drug Transfer Products Offered
10.4.5 Simplivia Healthcare Ltd. Recent Development
10.5 Corvida Medical
10.5.1 Corvida Medical Company Information
10.5.2 Corvida Medical Introduction and Business Overview
10.5.3 Corvida Medical Closed System for Drug Transfer Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Corvida Medical Closed System for Drug Transfer Products Offered
10.5.5 Corvida Medical Recent Development
10.6 B. Braun
10.6.1 B. Braun Company Information
10.6.2 B. Braun Introduction and Business Overview
10.6.3 B. Braun Closed System for Drug Transfer Sales, Revenue and Gross Margin (2018-2023)
10.6.4 B. Braun Closed System for Drug Transfer Products Offered
10.6.5 B. Braun Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Closed System for Drug Transfer Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Closed System for Drug Transfer Industrial Chain Analysis
11.4 Closed System for Drug Transfer Market Dynamics
11.4.1 Closed System for Drug Transfer Industry Trends
11.4.2 Closed System for Drug Transfer Market Drivers
11.4.3 Closed System for Drug Transfer Market Challenges
11.4.4 Closed System for Drug Transfer Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Closed System for Drug Transfer Distributors
12.3 Closed System for Drug Transfer Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
